SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001144204-12-003940
Filing Date
2012-01-25
Accepted
2012-01-25 17:14:22
Documents
3
Period of Report
2012-01-25
Filing Date Changed
2012-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v300378_8-k.htm 8-K 16878
2 PRESS RELEASE v300378_ex99-1.htm EX-99.1 15707
4 GRAPHIC logo.gif GRAPHIC 5198
  Complete submission text file 0001144204-12-003940.txt   41091
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 12545341
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10